脑机接口
Search documents
脑机接口迎重大利好
21世纪经济报道· 2026-01-29 14:39
Core Viewpoint - The recent approval of two medical device industry standards by the National Medical Products Administration (NMPA) marks a significant step towards the high-quality development of brain-computer interface (BCI) technologies in the medical field, providing essential support for standardization and regulation [1][2]. Group 1: Standardization and Development - The two newly established standards focus on the design and application of BCIs for medical devices, specifically addressing issues related to motor function rehabilitation and the reliability of invasive devices [7]. - The BCI market in China is projected to reach 3.2 billion yuan in 2024, with an 18.8% year-on-year growth, and is expected to grow to 5.58 billion yuan by 2027, reflecting a 20% growth rate [6]. - The establishment of these standards is a response to the challenges faced by the BCI industry, including terminology confusion, fragmented technology layout, and lack of unified regulations, which have hindered rapid development [6][7]. Group 2: Policy and Industry Resonance - Recent policies have positioned BCIs as a key future industry, with the 14th Five-Year Plan highlighting their potential as a new engine for economic growth [9]. - The NMPA has prioritized the approval of implantable BCI medical devices, expediting the market entry of innovative products [9]. - The commercial process for BCIs is expected to accelerate, with significant policy support and technological advancements driving rapid industry growth [10]. Group 3: Future Development and Market Dynamics - The future vision for the BCI industry includes cultivating globally influential leading enterprises and a number of specialized small and medium-sized enterprises by 2030 [11]. - Potential applications in the medical field are expected to expand beyond mere functional restoration to include "functional enhancement" applications, utilizing a combination of multiple devices and technologies [11].
科技向善凝共识!AI治理登顶“2025十大科技热词”榜首
Nan Fang Du Shi Bao· 2026-01-29 13:37
Group 1: AI Governance - The term "AI governance" ranks first among the "Top Ten Technology Buzzwords" for 2025, indicating a recognition within the Chinese tech community that technological excellence must align with governance wisdom for sustainable development [1] - The emphasis on AI governance reflects public concerns regarding AI ethics and safety, marking a global shift from "technology catching up" to "rule shaping" [1][2] - AI governance is described as a systematic project that integrates technological control, legal regulations, industry collaboration, and public education, aiming to guide AI development in alignment with human common interests [1] Group 2: Emerging Technologies - "Embodied intelligence" is included in the government work report for the first time in 2025, signaling a positive policy direction aimed at advancing AI technology and fostering new industrial development [4] - The International Thermonuclear Experimental Reactor (ITER) organization announced a milestone achievement in controlled nuclear fusion technology, with China playing a crucial role in this international collaboration [5] - Significant progress has been made in the brain-computer interface industry in 2025, with breakthroughs in core technologies and applications, laying a solid foundation for large-scale development [6] Group 3: Commercial Space and Deep Technologies - China's commercial space industry has gained attention, with operational capabilities established at various launch sites and a growing number of private rocket companies achieving successful launches [7] - "Deep-sea technology" is highlighted in the government work report as a new industry to be promoted, particularly in the context of the Hainan Free Trade Port [8] - The successful launch of the Tianwen-2 probe marks a significant step in China's deep space exploration efforts, following previous lunar and Mars missions [9] Group 4: Aging Population and Smart Technology - The intersection of aging population and technological revolution is driving innovation in "silver economy" technologies, with the establishment of a technology park in Shanghai aimed at enhancing elderly care services [10] - 2025 is projected to be the year of industrialization for "intelligent agents," with IDC predicting that by 2026, about 50% of data teams in China's top 500 companies will utilize intelligent agents for data preparation and analysis [11] Group 5: Innovation Recognition - "Chinese innovation" is recognized as a global buzzword in 2025, with China's innovation index ranking among the top ten worldwide, showcasing remarkable achievements in technology [12]
海峡创新:公司智慧医疗板块主要开展医疗器械代理相关业务,暂未涉及脑机接口领域
Mei Ri Jing Ji Xin Wen· 2026-01-29 13:12
每经AI快讯,有投资者在投资者互动平台提问:公司智慧医疗设计脑机领域吗?有何切入口? 海峡创新(300300.SZ)1月29日在投资者互动平台表示,公司智慧医疗板块主要开展医疗器械代理相关 业务,暂未涉及脑机接口领域。未来公司将持续关注前沿科技领域的发展及应用,探索行业相关技术与 公司现有业务的融合机会。 (记者 张明双) ...
尹烨与高德康为韩璧丞见证荣誉时刻,2025企业家之夜举行
Xin Lang Cai Jing· 2026-01-29 12:17
Core Viewpoint - The event "Praise for China's Economy - Entrepreneur Night" highlighted the achievements of Qiangnao Technology, a leader in non-invasive brain-computer interface technology, and its impact on improving the lives of disabled individuals [1][8]. Group 1: Company Achievements - Qiangnao Technology, led by CEO Han Bicheng, has become a global leader in non-invasive brain-computer interface technology, breaking foreign monopolies and turning science fiction into reality through ten years of technological innovation [3][10]. - The company has developed advanced products such as intelligent bionic hands and legs, which have restored life capabilities to disabled individuals and provided hope to over a thousand children with autism [3][10]. - The company aims to use cutting-edge technology to help approximately 5 million people in China with limb disabilities regain their ability to work and live independently [4][12]. Group 2: Social Impact - The technology developed by Qiangnao is not just about high-tech solutions but focuses on restoring the lives of individuals who have faced significant challenges due to disabilities [6][13]. - A notable case involved a user who had lost a hand for 27 years, who expressed that the technology allowed him to feel as if he had his hand back after successfully using a bionic prosthetic to grasp a cup [6][13]. - The company is also working on products aimed at addressing sleep issues, highlighting the broader applications of brain-computer interface technology in improving quality of life [7][14].
中国多地竞逐脑机接口新赛道
Zhong Guo Xin Wen Wang· 2026-01-29 12:07
中国省级地方两会近期陆续召开,脑机接口被写入多地政府工作报告中,围绕这一未来产业的区域竞逐 赛正加速展开。 随着创新成果不断涌现和应用探索不断深入,脑机接口市场或将迎来高速增长。据中国信通院测算, 2026年中国脑机接口产业规模预计达数十亿元,2030年的中国市场预计可达100亿元至140亿元。 面对这一未来产业,北京、上海、山东、四川等中国多地相继出台政策,加速产业布局。江西从强化科 技创新引领、推动成果转化应用、加快创新主体引育、提升产业支撑能力四个方面,部署11项重点任 务,推动脑机接口科技创新和产业创新深度融合。 江西省政协常委、农工党江西省委会专职副主委林凯表示,江西推动脑机接口技术产学研医融合起步发 展,已具备打造神经工程产业集聚区的基础条件,处于从技术突破到产业集聚的关键阶段。 尽管前景广阔,脑机接口从技术到产业仍面临诸多瓶颈。业内人士指出,对于一个从无到有的新兴行业 来说,建立标准至关重要。 中国工业和信息化部等七部门2025年联合印发的《关于推动脑机接口产业创新发展的实施意见》提出, 到2027年,中国脑机接口关键技术取得突破,初步建立先进的技术、产业、标准体系。脑机接口产品加 快应用,产业 ...
2月金股报告:指数震荡,行业关注资源、出海、科技
ZHONGTAI SECURITIES· 2026-01-29 11:18
Group 1 - The report indicates that the A-share market is experiencing a typical spring rally characterized by initial strength followed by stabilization and structural differentiation, with major indices recording positive returns as of January 28, 2026 [6] - The average daily trading volume in January reached 3.04 trillion yuan, an increase of 1.16 trillion yuan month-on-month, indicating a significant influx of new capital and a loose liquidity environment driving the index upward [2] - Regulatory measures, including raising the minimum margin requirement from 80% to 100%, have led to fluctuations in market sentiment and a deceleration in the index's upward momentum [3] Group 2 - The report highlights that technology assets are experiencing a rotation between thematic and cyclical investments, with thematic investments (e.g., commercial aerospace, AI applications) initially favored but cooling off due to increased margin requirements [4] - In the cyclical sector, non-ferrous metals, basic chemicals, and oil & petrochemicals have shown strong performance driven by three factors: demand from high-end manufacturing, proactive supply-side adjustments, and external geopolitical risks [4] - The report anticipates a structural market characterized by a focus on "resources + technology + overseas expansion," with low-risk preference assets potentially outperforming in certain phases [5] Group 3 - The investment strategy emphasizes focusing on "external demand cyclical + AI industry chain," highlighting the potential for global manufacturing recovery to support resource prices and opportunities for Chinese manufacturing to expand overseas [5] - The AI industry remains a clear investment theme, with a shift from thematic to performance-driven investments, particularly in areas with supply shortages such as power supply and semiconductor sectors [5] - The report recommends a selection of stocks across various sectors, including Invesco's Nonferrous ETF, Dongpeng Beverage, and Huazhong Precision, among others, reflecting a diversified investment approach [10]
科创板七载深耕启新程!金融界“科创汇”重磅启幕,赋能硬科技高质量发展
Jin Rong Jie· 2026-01-29 10:46
Core Insights - The Sci-Tech Innovation Board (STAR Market) has achieved significant milestones in its seven years of operation, with over 600 listed companies and a total market capitalization exceeding 10 trillion yuan, raising over 1.1 trillion yuan through IPOs and refinancing [1] - The "Sci-Tech Exchange" initiative aims to address industry development challenges and promote a virtuous cycle of technology, industry, and capital by connecting various stakeholders [1][2] Group 1: STAR Market Achievements - The STAR Market has become a core platform for nurturing new productive forces and promoting technological self-reliance, characterized by high levels of innovation, technology, and capital [1] - The board's reforms have expanded the scope of the fifth set of standards to include cutting-edge fields such as embodied intelligence, chips, large models, brain-computer interfaces, and commercial aerospace [1][5] Group 2: Sci-Tech Exchange Initiative - The "Sci-Tech Exchange" initiative focuses on four core objectives: value discovery, benchmark establishment, resource linking, and ecosystem co-construction [2] - The initiative will conduct in-depth analysis and research on five key cutting-edge fields, ensuring a comprehensive approach to industry chain integrity and technological innovation [5] Group 3: Communication and Impact - The initiative will utilize a multi-format communication strategy, including text, video, live broadcasts, and offline events, to enhance its influence and reach [6] - A comprehensive research campaign will be conducted from February to June 2026, covering major innovation hubs in China to showcase the vitality of the country's sci-tech industry [6]
创新医疗:预计2025年全年扣非后净利润亏损6800万元至7500万元
Sou Hu Cai Jing· 2026-01-29 10:23
2、本报告期扣除非经常性损益后的净利润出现同比下降,主要系:在医保政策以及医保支付标准持续 调整的行业背景下,康华医院、建华医院对短期盈利预期的不确定性进行了审慎评估,本报告期确认的 递延所得税资产同比减少,导致所得税费用出现同比上升。 证券之星消息,创新医疗发布业绩预告,预计2025年全年扣非后净利润亏损6800万元至7500万元。 公告中解释本次业绩变动的原因为: 1、本报告期归属于上市公司股东的净利润出现同比上升,主要系:公司增持博灵脑机股权并将该公司 纳入合并报表范围,根据《企业会计准则第 33 号——合并财务报表》第四十八条的规定,确认了相应 的投资收益;李晔案件再审改判后,建华医院收到了法院返还的被执行款项,并由此确认了营业外收 入。 创新医疗2025年三季报显示,前三季度公司主营收入5.97亿元,同比下降2.11%;归母净利润472.44万 元,同比上升116.97%;扣非净利润-2946.98万元,同比上升6.05%;其中2025年第三季度,公司单季度 主营收入1.96亿元,同比下降3.16%;单季度归母净利润1608.57万元,同比上升236.15%;单季度扣非 净利润-1658.58万元, ...
创新医疗:预计2025年全年营业收入7.8亿元至8亿元
Sou Hu Cai Jing· 2026-01-29 10:23
创新医疗2025年三季报显示,前三季度公司主营收入5.97亿元,同比下降2.11%;归母净利润472.44万 元,同比上升116.97%;扣非净利润-2946.98万元,同比上升6.05%;其中2025年第三季度,公司单季度 主营收入1.96亿元,同比下降3.16%;单季度归母净利润1608.57万元,同比上升236.15%;单季度扣非 净利润-1658.58万元,同比下降12.36%;负债率17.84%,投资收益2950.55万元,财务费用60.55万元, 毛利率10.08%。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 1、本报告期归属于上市公司股东的净利润出现同比上升,主要系:公司增持博灵脑机股权并将该公司 纳入合并报表范围,根据《企业会计准则第 33 号——合并财务报表》第四十八条的规定,确认了相应 的投资收益;李晔案件再审改判后,建华医院收到了法院返还的被执行款项,并由此确认了营业外收 入。 2、本报告期扣除非经常性损益后的净利润出现同比下降,主要系:在医保政策以及医保支付标准持续 调整的行业背景下,康华医院、建华医院 ...
不止具身智能?傅利叶称1-2年内将脑机接口引入机器人康复训练
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-29 10:18
这不是科幻,机器人要和脑机接口结合,并在康养场景落地。 1月28日,上海张江,在第二届傅利叶具身智能生态峰会暨张江机器人开发者先锋大会上,傅利叶智能 创始人顾捷抛出了一个清晰的时间表:其融合脑机接口技术的康复机器人解决方案,将在未来1至2年内 实现规模化落地。 顾捷称,"当患者在训练过程中产生了运动意图,但肌肉水平却又无法完成时,机器人能够通过脑机识 别意图,在意识形成的当下提供恰当的助力,就完成了一次从中枢到外周的完整闭环训练。" 脑机技术成熟 脑机接口并非新概念。科幻电影《黑客帝国》、《环太平洋》早已描绘了人类意识操控机械的瑰丽想 象。在医疗领域,十年前美国加州理工学院的演示——让瘫痪患者通过脑内芯片控制机械臂喝啤酒—— 曾震撼世界。然而,从震撼演示到稳定、可规模化的临床产品,这条路上布满了工程荆棘。 此外,值得一提的关键突破,源于软件与算法层,即大模型的革命性赋能。 "以前处理脑电信号,主要依赖FFT(快速傅里叶变换)、频谱分析等传统处理方法。这些方法在处理 非线性、高维度的脑电信号时,能力非常有限。"顾捷指出,"但基于大模型,我们发现可以更有效地对 复杂的脑电信号进行分类和解析,从而实现更精准的意图识 ...